Golimumab (MK-8259 / SCH900259) Treatment Withdrawal in Participants With Non-radiographic Axial Spondyloarthritis (GO-BACK) (MK-8259-038)

NCT03253796 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

323

Enrollment

INDUSTRY

Sponsor class

Conditions

Spondyloarthritis

Interventions

BIOLOGICAL: Golimumab
BIOLOGICAL: Placebo

Sponsor

Merck Sharp & Dohme LLC